Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Whitehawk Therapeutics, Inc.
13D/A
Amendment 2
WHWK · 00032Q104
|
9.0% |
5/18/2026
Event 5/14/2026
|
|||
| Acuta Capital Partners, LLC | 8.7% | ||||
| Anupam Dalal | 9.0% | ||||
| Acuta Capital Fund, LP | 6.6% | ||||
|
Aadi Bioscience, Inc.
13D/A
Amendment 1
WHWK · 00032Q104
|
7.8% |
1/24/2025
Event 12/19/2024
|
|||
| Acuta Capital Partners, LLC | 7.5% | ||||
| Anupam Dalal | 7.8% | ||||
| Acuta Capital Fund, LP | 6.4% | ||||